ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells
- 31 March 2013
- journal article
- research article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1833 (3), 752-760
- https://doi.org/10.1016/j.bbamcr.2012.12.009
Abstract
No abstract availableKeywords
Funding Information
- Région Picardie
- Ministère de l'Éducation Nationale
- La Ligue Nationale Contre le Cancer
This publication has 35 references indexed in Scilit:
- Orai3 – the ‘exceptional’ Orai?The Journal of Physiology, 2012
- A Novel Native Store-operated Calcium Channel Encoded by Orai3Published by Elsevier BV ,2010
- Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migrationAmerican Journal of Physiology-Cell Physiology, 2010
- NFAT-Induced Histone Acetylation Relay Switch Promotes c-Myc-Dependent Growth in Pancreatic Cancer CellsGastroenterology, 2010
- Voltage-gated potassium channels as therapeutic targetsNature Reviews Drug Discovery, 2009
- Stim1 and Orai1 Mediate CRAC Currents and Store-Operated Calcium Entry Important for Endothelial Cell ProliferationCirculation Research, 2008
- Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathwayThe EMBO Journal, 2006
- A mutation in Orai1 causes immune deficiency by abrogating CRAC channel functionNature, 2006
- Cancer therapeutics: Targeting the dark side of MycEuropean Journal Of Cancer, 2005
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001